Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
EPRX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -23.8%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
eupraxia
pharmaceuticals
eosinophilic
esophagitis
phase
market
104gi
million
data
trading
announced
resolve
results
2025
clinical
treatment
public
offering
after
nasdaq
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
StonvexStonvexStonvexStonvex